Tower Research Capital (TRC)’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-3,724
| Closed | -$24K | – | 6658 |
|
|
2022
Q4 | $24K | Sell |
3,724
-28,574
| -88% | -$184K | ﹤0.01% | 2983 |
|
|
2022
Q3 | $165K | Buy |
+32,298
| New | +$165K | ﹤0.01% | 2113 |
|
|
2022
Q2 | – | Sell |
-3,065
| Closed | -$11K | – | 6864 |
|
|
2022
Q1 | $11K | Sell |
3,065
-7,680
| -71% | -$27.6K | ﹤0.01% | 4250 |
|
|
2021
Q4 | $54K | Buy |
10,745
+10,574
| +6,184% | +$53.1K | ﹤0.01% | 2716 |
|
|
2021
Q3 | $1K | Buy |
+171
| New | +$1K | ﹤0.01% | 5615 |
|
|
2020
Q4 | – | Sell |
-1,553
| Closed | -$8K | – | 5506 |
|
|
2020
Q3 | $8K | Sell |
1,553
-406
| -21% | -$2.09K | ﹤0.01% | 4210 |
|
|
2020
Q2 | $11K | Buy |
+1,959
| New | +$11K | ﹤0.01% | 3987 |
|
|
2019
Q3 | – | Sell |
-1,507
| Closed | -$22K | – | 4667 |
|
|
2019
Q2 | $22K | Buy |
1,507
+1,171
| +349% | +$17.1K | ﹤0.01% | 2133 |
|
|
2019
Q1 | $14K | Buy |
+336
| New | +$14K | ﹤0.01% | 2494 |
|
|
2018
Q4 | – | Sell |
-155
| Closed | -$7K | – | 4530 |
|
|
2018
Q3 | $7K | Buy |
+155
| New | +$7K | ﹤0.01% | 2985 |
|
|
2018
Q2 | – | Sell |
-61
| Closed | -$4K | – | 4213 |
|
|
2018
Q1 | $4K | Buy |
61
+42
| +221% | +$2.75K | ﹤0.01% | 2820 |
|
|
2017
Q4 | $1K | Sell |
19
-31
| -62% | -$1.63K | ﹤0.01% | 3394 |
|
|
2017
Q3 | $3K | Buy |
+50
| New | +$3K | ﹤0.01% | 3507 |
|
|
2016
Q4 | – | Sell |
-177
| Closed | -$8K | – | 4570 |
|
|
2016
Q3 | $8K | Sell |
177
-219
| -55% | -$9.9K | ﹤0.01% | 2251 |
|
|
2016
Q2 | $15K | Buy |
+396
| New | +$15K | ﹤0.01% | 2494 |
|